2015年12月?？贾辈cca考卷精講

沖刺期間任 問題請(qǐng)私聊小TutorIntroduction_ScottMBA,FudanFCCA&CICPA7years’practicalexperienceinBig4AccountingFirmsand4years’experienceinInvestmentGroup8years’experienceintutoringACCA(Spring&Autumn)Takeall14examsin3SectionA–SectionA–Q1-ExamPoint:conceptualAccountingAccrualbasisGoingconcernFaithfulSubstanceoverform-e.g.financeNeutrality–from

SectionA–SectionA–Q2-ExamPoint:conceptualframeworkSectionA–SectionA–Q3-ExamPoint:conceptualSectionA–SectionA–Q4-ExamPoint:PPE-CostAnyamountsincurredtoacquiretheassetandbringitintoworkingPurchasecost:purchaseprice,importduties,freight,non-refundabletaxesetc.Directlyattributablecosts:professionalcosts,sitepreparationcosts,installation,testingetc.TheestimatedcostofdismantlingandremovingtheassetandrestoringthesiteCostsofintroducinganewproductorInitialoperatinglossesbeforetheassetreachesnnedStartup

SectionA–SectionA–Q5-ExamPoint:InvestmentHeldtoearnrentalsand/orforcapitalCostRecog,initialandsub.measurement:sameasRevaluationGain/lossonrevaluationshouldberecordedinprofitorNo

SectionA–SectionA–Q6-ExamPoint:CapitalizedTheinterestoftheloancanbecapitalizedfromMarch1toOctober31.SectionA–

SectionA–Q7-ExamPoint:IntangibleassetsActivemarketRevaluationToFVifactivehomogenouswillingbuyers/sellersanypricesavailabletotheNoactivemarket?costRevaluewholeRevalueregularlysuchthatBVnotmateriallydiffto

SectionA– ExamPoint:PPEimpairmentCarryingamount:120,000Recoverableamount:FVlesscoststosell:Valueinuse:

SectionA–SectionA–Q9-ExamPoint:Biological

SectionA–Q9-Biologicalassetsaremeasuredbothoninitialrecognitionandattheendofeachreportingperiodatfairvaluelesscoststosell.ChangesinfairvaluelesscoststosellarerecognisedinprofitorChangesin0450450*$800450*$900each(3150Sales:150*$840SectionA–SectionA–Q10-ExamPoint:Provision(largeLargepopulation?expectedvaluesSingleobligation?mostlikelyeDiscountifmaterialAccrualamount:Expectedvalue:Less:Usedamount:400*40=16,000Endingbalance:24,000

SectionA–SectionA–Q11-ExamPoint:AFSChangesinAFS:othercomprehensiveAtthedateofOthercomprehensivee:FV@disposaldate–FV@openingP&L:revaluationsurplustransfertoP&L

SectionA–SectionA–Q12-ExamPoint:SubstanceoverSaleandAccountforasloansellerretainsbenefitsofuseofrepurchase

SectionA–SectionA–Q13-DeferredtaxP&Limpact:ChangesinSectionA–SectionA–Q14-ExamPoint:Ratios(notveryreasonable)ROCE=Netprofit/Equity(deemednolong-termliability)Netprofitmargin=Netprofit/salesAssetturnover=Sales/SectionA–SectionA–Q15-ExamPoint:Cashcycle&Cashcycle=Inventorydays+receivabledays–payabledaysReceivabledays=receivable/creditsales*365SectionA–SectionA–Q16-ExamPoint:conceptualSectionA–SectionA–Q17-ExamPoint:Investment–EquityaccountingDefinitionofcontrolandsignificantinfluenceSectionA–SectionA–Q18-Exam ernmentWillcomplywiththeconditionsofthegrantWillreceivethegrantAccounting-Grantsrelatingto-Grantsrelatingto-RepaymentofNon-monetarygrantsFairvalueNominalSectionA–SectionA–Q19-ExamPoint:SalesandoperationleaseLeasebackasoperatingSaleproceeds=-recogniseprofit/loss Saleproceeds<-recogniseprofit/lossimmedia yunlesslossiscompensatedbyrentalsat<marketprice?defer&amortiseoverperiodassetexpectedtobeSales:priceMarketprice:Belowmarketprice:300,000shouldbeamortizedinleaseperiod(6 50,000expenseeachyear NetP&Limpact:lease100,000+50,000=150,000

SectionA–SectionA–Q20 ExamPoint:conceptual

Question1:CFstatement15PPE:includingsalesandoperatingleaseback/financelease(veryPPEmovement:opening+cashaddition+financelease+revaluation-depreciation–disposal(NBV)=ending1700+cashaddition+400+100-310–670=2300cashaddition=Gain/(loss)ondisposal=cashproceeds–disposal(NBV)=800-Opening:Ending:Financelease:400Initialrecognition:Dr.PPECr.FinancialleasepayableRevaluation:100(gainonpropertyrevaluation)Disposal(NBV):670FinanceleaseFinanceleaseliability:Opening+Financeleaseaddition+financecost–payment=250+400+40-payment=480repaymentoffinancelease(financingactivity)Interestpayment=40(operatingcashPrinciplepayment=210-40=170(balancingfigure,financingcashProfitonsalesandoperatingleaseback:marketprice=salesproceedsprofit=800-670=130(operatingcashCurrenttaxpayable:Opening+currenttaxexpense–taxpayment=Deferredtaxexpense=changesinDTL=-Dr.DTLCr.Deferredtaxexpense etaxexpense=currenttaxexpense+deferredtaxexpenseCurrenttaxexpense=90+10=100Taxpayment=Opening+currenttaxexpenses–ending=80Tradableinvestment:Opening220+Purchase(investingcashflow)+gain30 Purchaseoftradableinvestment=Interestreceived=40-Impairmentofgoodwill:250-220=30(operatingRightissue:cashreceipt(sharecapital+sharepremium)=300+120Dividend=Cashandcashequivalent:includingbankQuestion2:Separatefinancialstatement15ExamPPErevaluation&depreciationLease(OperatingorFinance)--subsequentAmortisedcost(almostAmortisedcost(almostTaxInventoryPPE&InvestmentRevaluationsurplus/othercomprehensivee10,000taximpact(noteCostA.D.NBV35,000/35yrstaximpact(note2)Depreciation=175,000/35=5,000(costofDepreciation=130,000*15%=19,500(costofFairvaluechangeofInvestmentproperty:90,000*7%=Deferredtaxexpense=changesinDTL=23.1-9-12.5=1,600(‘000)Currenttaxexpense=28,300etaxexpense=TaximpactfromgainonpropertyrevaluationFinanceInitialDr.ntCr.FinanceleasepayableCurrentDepreciation:92,000/5=18,400(costofsales)Financeexpense:(92,000-22000)*10%=7,000Financeleasepayable@Year1:92,000+7,000-22,000=77,000Financeleasepayable@Year2:77,000+5,500-22,000=60,500Financeleasepayable:current:17,500,non-current:60,500

AmortisedLoannoteopeningInterestpaid=50,000*4%/2=1,000Interestexpense=Ending4%loannote=Inventorylostas:,800+re0it:0=:24,500TrialbalancepaidnotincludingFinancelease7,000Amortisedcost:

Question3:ConsolidatedFinancialStatements30Goodwill@acquisitionConsideration–share80%Sshareno.=10,000*80%Cashpart=8,000*1=8,000Sharepart=8,000/2*9.6=38,400(notrecord)Dr.Investment38,400Cr.Sharecapital4,000Cr.Sharepremium34,400(consolidation)Totalconsideration=8,000+38,400=46,400NetassetsofS@acq.Date=Fairvalueappreciation=3,200–500(li